Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

ANRS, Emerging Infectious Diseases · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
exposureprophylaxislongmsmpersistenceprepprevention
prevention, hiv pre-exposure prophylaxis, prep, msm, long-acting injectable, cabotegravir, tdf/ftc, persistence, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 917474
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.